Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
MedPlus Health Services informed stock exchanges that its subsidiary, Optival Health Solutions Private Limited, received a one-day suspension order for the drug license of a store located in Kuntloor, Telangana. The order was issued by the Assistant Director, Drugs Control Administration, Rangareddy, and received on February 27, 2026. The action was taken under Rule 65 of the Drugs and Cosmetics Act, 1940 and the related Rules of 1945. The company has stated the potential revenue loss from this single-day suspension is approximately Rs 0.42 lakhs (around Rs 42,000).
The financial impact is negligible at roughly Rs 42,000, so this is unlikely to affect the stock price or shareholder value meaningfully. However, repeated license actions across stores could indicate compliance risks worth monitoring over time.